MTOR and cancer: The phosphatidylinositol 3‐kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway, one of the most commonly activated signalling pathways in many human cancers, is a key signalling pathway that controls cell growth, differentiation and metabolism.7